Gilead Highlights P-III (ASCENT-03) Trial Data of Trodelvy for Triple-Negative Breast Cancer (TNBC) at ESMO 2025
Shots: Ref: Gilead| Image: Gilead| Press Release Related News:- Gilead Reports the EC’s Approval of Yeytuo (Lenacapavir)…
Read article →
Glaukos Receives FDA Approval for Epioxa
Shots: Ref: Glaukos | Image: Glaukos | Press Release Related News:- Genentech Reports the US FDA’s Approval of Gazyva…
Read article →
EMA Marketing Authorization of New Drugs in September 2025
Shots: Company: Deciphera Pharmaceuticals Product: Romvimza Active Ingredient: Vimseltinib Disease: Symptomatic…
Read article →
LIFE SCIENCES | DAILY NEWS | OCT 21, 2025 | PHARMASHOTS
The post LIFE SCIENCES | DAILY NEWS | OCT 21, 2025 | PHARMASHOTS appeared first on PharmaShots.
Read article →
Boston Scientific to Acquire Nalu Medical for ~$533M
Shots: Ref: Boston Scientific | Image: Nalu Medical | Press Release Related News:- Boston Scientific’s Farapulse PFA…
Read article →
PharmaShots Weekly Snapshots (Oct 13, 2025 – Oct 17, 2025)
This week, PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, DigiHealth,…
Read article →
LIFE SCIENCES | DAILY NEWS | OCT 17, 2025 | PHARMASHOTS
The post LIFE SCIENCES | DAILY NEWS | OCT 17, 2025 | PHARMASHOTS appeared first on PharmaShots.
Read article →
FDA Approves Celltrion’s Yuflyma (Biosimilar, Humira) and its Unbranded Version for Hidradenitis Suppurativa (HS) and Uveitis in Younger Patients
Shots: Ref: Celltrion | Image: Celltrion| Press Release Related News:- Celltrion’s Eydenzelt (Biosimilar, Eylea)…
Read article →